Impact of statin dose on major cardiovascular events: A mixed treatment comparison meta-analysis involving more than 175,000 patients  Rodrigo Antonini.

Slides:



Advertisements
Similar presentations
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Primary Prevention of Cardiovascular Mortality and.
Advertisements

Fellows' perspectives on training in adult congenital heart disease: Results of a survey from the International Society for Adult Congenital Heart Disease.
The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated.
From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis Ann Intern Med. 2012;157(4):
Volume 355, Issue 9212, Pages (April 2000)
Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J
V. Atella, A. Brady, A. L. Catapano, J. Critchley, I. M. Graham, F. D
Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH 
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal  Gregory.
Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis  Sarah A. Anderson, John.
Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies  Xia Wang, Yingying.
Meta-analysis of randomised controlled trials
Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis  M.S. Corbett, S.J.C. Rice,
American Journal of Kidney Diseases 
Support with intra-aortic balloon pump vs. Impella2
Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial  Annelise C. Costanza,
Management of hypertension in patients with chronic kidney disease
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.
Erik O. Udo, Norbert M. van Hemel, Nicolaas P. A
Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations  Judith A. Finegold,
The US Renal Data System “Pie Chart of Death”
Marc Carrier, MD, MSc, Alok A
Olivier Luc Charansonney, Luc Vanhees, Alain Cohen-Solal 
What evidence is good evidence? A Masterclass in critical appraisal
PDE5 inhibitor sildenafil in the treatment of heart failure: A meta-analysis of randomized controlled trials  Xiao-Dong Zhuang, Ming Long, Fei Li, Xun.
Quantitating the Dose of Physical Activity in Secondary Prevention: Relation of Exercise Intensity to Survival  Barry A. Franklin, PhD  Mayo Clinic Proceedings 
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
Unknown ankylosing spondylitis with only cardiac involvement in patient with surgical indication: Call for patient and family members immunological screening 
Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?  Maura Ravera, Elisabetta.
Impact of non-cardiovascular disease comorbidity on cardiovascular disease symptom severity: A population-based study  C.A. Rushton, U.T. Kadam  International.
Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study  Vasilios Papademetriou, MD, DSc, Eric.
Incident diabetes in clinical trials of antihypertensive drugs
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Why surgery won the SYNTAX trial and why it matters
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Adrian Martineau  The Lancet Respiratory Medicine 
The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled.
Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review  B.A. de Waal, M.P. Buise, A.A.J. van.
Kamran Manzoor, Waqas Aftab, Sonia Choksi, Ijaz A. Khan 
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.
Clinical importance of short–long–short sequences: Analysing the mode of onset of ventricular tachycardias and atrial fibrillation  Bulent Gorenek  International.
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Volume 371, Issue 9627, Pages (May 2008)
Volume 382, Issue 9894, Pages (August 2013)
Experiences of air travel in patients with chronic heart failure
Volume 76, Issue 11, Pages (December 2009)
Inspiratory muscle training reduces blood pressure and sympathetic activity in hypertensive patients: A randomized controlled trial  Janaína Barcellos.
Volume 73, Issue 12, Pages (June 2008)
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease  Tetsuro Tsujimoto, Hiroshi Kajio 
International Journal of Cardiology
Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression  Corline Brouwers, Stefan.
Age-dependent care and long-term (20year) mortality of 14,434 myocardial infarction patients: Changes from 1985 to 2008  Sjoerd T. Nauta, Jaap W. Deckers,
Erratum to “Tako-tsubo cardiomyopathy may be associated with cardiac geometric features as observed in hypertensive heart disease” [Int. J. Cardiol. 135.
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction 
Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study  Hiroshi.
Reported cardiac phenotypes in hereditary hemorrhagic telangiectasia emphasize burdens from arrhythmias, anemia and its treatments, but suggest reduced.
International Journal of Cardiology
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
The “obesity paradox” in an elderly population with a high prevalence of Chagas disease: The 10-year follow-up of the Bambuí (Brazil) Cohort Study of.
Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: The Whitehall II study  Alexis Elbaz,
Cardiac ion channel mutations in the sudden infant death syndrome
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled.
International Journal of Cardiology
Presentation transcript:

Impact of statin dose on major cardiovascular events: A mixed treatment comparison meta-analysis involving more than 175,000 patients  Rodrigo Antonini Ribeiro, Patricia Klarmann Ziegelmann, Bruce Bartholow Duncan, Steffan Frosi Stella, José Luiz da Costa Vieira, Luciane Maria Fabian Restelatto, Emílio Hideyuki Moriguchi, Carisi Anne Polanczyk  International Journal of Cardiology  Volume 166, Issue 2, Pages 431-439 (June 2013) DOI: 10.1016/j.ijcard.2011.10.128 Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 Flow diagram of the studies' selection process. CHF = Chronic Heart Failure, CKD = Chronic Kidney Disease. *The SEARCH study was retrieved as a study protocol in the moment of the MEDLINE search. Later, its original publication data, released in 2010, was incorporated in the meta-analysis. **Ward et al. [1]. International Journal of Cardiology 2013 166, 431-439DOI: (10.1016/j.ijcard.2011.10.128) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 2 Geometric distribution of analysis. Network of evidence formed by the three statin groups and the no statin arm. The numbers accompanying the arrows indicate the number of trials for that link in the network. Two studies are counted three times in this figure, since they included three arms (high and intermediate doses and placebo) and therefore appear in three analyses. International Journal of Cardiology 2013 166, 431-439DOI: (10.1016/j.ijcard.2011.10.128) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 3 Mixed treatment comparison analysis of myocardial infarction, stratified by type of prevention. The total number of events in the primary prevention MTC model was 1394, and in the secondary model, 4591 (the sum of these values is not equal to the total event number of the MI non-stratified model, since mixed population studies were not included in the stratified analysis). International Journal of Cardiology 2013 166, 431-439DOI: (10.1016/j.ijcard.2011.10.128) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 4 Consistency analyses for the MI mixed treatment comparisons. Posterior densities of the mean log-relative risk calculated using the full MTC model (solid line), and direct (dotted line) and indirect (dashed line) analyses, when each node is split. International Journal of Cardiology 2013 166, 431-439DOI: (10.1016/j.ijcard.2011.10.128) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions